NCT02580149View on ClinicalTrials.gov

The Effect of Ticagrelor or Clopidogrel on Endothelial Function During Acute and Chronic Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

July 31, 2016

Conditions
Ischemia
Interventions
DRUG

Ticagrelor

"Subjects will receive an oral loading dose of 180 mg ticagrelor on study day~1 followed by a maintenance dose of 90 mg twice daily for 14 days (until study day 15)."

DRUG

Clopidogrel

Subjects will receive a loading dose of 600 mg clopidogrel on the first study day followed by a maintenance dose of 75 mg once daily for 14 days

Trial Locations (1)

1090

Medical University of Vienna, Department of Clinical Pharmacology, Vienna

All Listed Sponsors
lead

Michael Wolzt, Prof. MD

OTHER

NCT02580149 - The Effect of Ticagrelor or Clopidogrel on Endothelial Function During Acute and Chronic Treatment | Biotech Hunter | Biotech Hunter